This biotech stock remains Top Pick at B.Riley despite recent outperformance

June 26, 2026 11:30 PM

Investing.com -- A rare-disease drug developer is entering a catalyst-rich second half of the year that could drive a re-rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found